Anzahl der Einträge: 2.
2021
van den Bent, Martin J.,
Tesileanu, C. Mircea S. ![ORCID 0000-0003-3541-9242](/images/orcid_16x16.gif)
,
Wick, Wolfgang,
Sanson, Marc,
Brandes, Alba Ariela,
Clement, Paul M.,
Erridge, Sarah,
Vogelbaum, Michael A.,
Nowak, Anna K. ![ORCID 0000-0002-9317-9526](/images/orcid_16x16.gif)
,
Baurain, Jean Français,
Mason, Warren P.,
Wheeler, Helen,
Chinot, Olivier L.,
Gill, Sanjeev,
Griffin, Matthew,
Rogers, Leland,
Taal, Walter ![ORCID 0000-0002-5530-7259](/images/orcid_16x16.gif)
,
Rudà, Roberta,
Weller, Michael,
McBain, Catherine,
Reijneveld, Jaap,
Enting, Roelien H.,
Caparrotti, Francesca,
Lesimple, Thierry,
Clenton, Susan,
Gijtenbeek, Anja,
Lim, Elizabeth,
Herrlinger, Ulrich,
Hau, Peter,
Dhermain, Frederic,
de Heer, Iris,
Aldape, Kenneth,
Jenkins, Robert B.,
Dubbink, Hendrikus Jan,
Kros, Johan M.,
Wesseling, Pieter,
Nuyens, Sarah,
Golfinopoulos, Vassilis,
Gorlia, Thierry,
French, Pim und
Baumert, Brigitta G.
(2021)
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
The Lancet Oncology 22 (6), S. 813-823.
Volltext nicht vorhanden.
2017
van den Bent, Martin J.,
Baumert, Brigitta,
Erridge, Sara C.,
Vogelbaum, Michael A.,
Nowak, Anna K. ![ORCID 0000-0002-9317-9526](/images/orcid_16x16.gif)
,
Sanson, Marc,
Brandes, Alba Ariela,
Clement, Paul M.,
Baurain, Jean Francais,
Mason, Warren P.,
Wheeler, Helen,
Chinot, Olivier L.,
Gill, Sanjeev,
Griffin, Matthew,
Brachman, David G.,
Taal, Walter,
Rudà, Roberta,
Weller, Michael,
McBain, Catherine,
Reijneveld, Jaap,
Enting, Roelien H.,
Weber, Damien C.,
Lesimple, Thierry,
Clenton, Susan,
Gijtenbeek, Anja,
Pascoe, Sarah,
Herrlinger, Ulrich,
Hau, Peter,
Dhermain, Frederic,
van Heuvel, Irene,
Stupp, Roger,
Aldape, Ken,
Jenkins, Robert B.,
Dubbink, Hendrikus Jan,
Dinjens, Winand N. M.,
Wesseling, Pieter ![ORCID 0000-0001-5453-5201](/images/orcid_16x16.gif)
,
Nuyens, Sarah,
Golfinopoulos, Vassilis,
Gorlia, Thierry,
Wick, Wolfgang und
Kros, Johan M.
(2017)
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
The Lancet 390 (10103), S. 1645-1653.
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Fri Aug 16 23:22:52 2024 CEST.